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In patients with chronic obstructive pulmonary disease (COPD), the lower respiratory tract is commonly
colonized by bacterial pathogens, including nontypeable Haemophilus influenzae. The H. influenzae HMW1 and
HMW2 adhesins are homologous proteins that promote bacterial adherence to respiratory epithelium and are the
predominant targets of the host immune response. These adhesins undergo graded phase variation, controlled by
the numbers of 7-bp repeats upstream of the HMW1 and HMW2 structural genes (hmw1A and hmw2A, respec-
tively). In this study, we examined the levels of HMW1 and HMW2 expressed by H. influenzae isolates collected
serially from patients with COPD. We found that expression of HMW1 and HMW2 in a given strain decreased over
time in a majority of patients, reflecting progressive increases in the numbers of 7-bp repeats and associated with
high serum titers of HMW1/HMW2-specific antibodies. We speculate that the presence of high titers of antibodies
against the HMW1 and HMW2 adhesins and other immune factors in the lower respiratory tracts of patients with
COPD may result in gradual selection for bacteria with reduced levels of HMW1 and HMW2.
Nontypeable Haemophilus influenzae is a common commen-
sal organism in the human upper respiratory tract and an
important cause of human respiratory tract disease (20). The
pathogenesis of H. influenzae respiratory tract disease begins
with bacterial colonization of the nasopharynx followed by
contiguous spread to the middle ear, the sinuses, or the lower
airways, resulting in localized disease at these sites (14).
Colonization of the respiratory epithelium by bacterial
pathogens requires adhesive molecules. The majority of non-
typeable H. influenzae clinical isolates express adhesins that
belong to a family of high-molecular-weight proteins called the
HMW1/HMW2 family (3). The prototype HMW1 and HMW2
proteins from H. influenzae strain 12 are 71% identical and
80% similar and are the predominant targets of the serum
antibody response during H. influenzae disease (2, 3). HMW1
and HMW2 are encoded by separate chromosomal loci, with
each locus consisting of three genes, designated hmwA, hmwB,
and hmwC (4, 5). The hmwA genes encode the surface-exposed
adhesins, and the hmwB and hmwC genes encode accessory
proteins required for proper processing and secretion of the
adhesins (4, 8, 17, 19). Based on examination of a large col-
lection of epidemiologically distinct isolates, all strains with
hmw genes appear to contain two hmw loci in conserved, un-
linked physical locations on the chromosome, including one
adjacent to open reading frame (ORF) HI1598 and one adja-
cent to ORF HI1679 (5). Functional analysis of the HMW
adhesins produced by a subset of these strains has demon-
strated that each isolate possesses one protein with HMW1-
like adherence properties and one with HMW2-like adherence
properties (5). Interestingly, in some strains the HMW1 adhe-
sin is encoded by the hmw locus adjacent to ORF HI1598, and
in others, the HMW1 adhesin is encoded by the hmw locus
adjacent to ORF HI1679 (5). As a corollary, in some strains
the HMW2 adhesin is encoded by the hmw locus adjacent to
ORF HI1679, and in others the HMW2 adhesin is encoded by
the hmw locus adjacent to ORF HI1598 (5).
Although the HMW1/HMW2 adhesins are critical for me-
diating attachment to human epithelial cells, these proteins
may also contribute to bacterial clearance by the host via their
immunogenicity. In earlier work, we discovered that HMW1
and HMW2 undergo phase variation in a graded fashion (7).
The levels of expression of HMW1 and HMW2 are influenced
by the numbers of tandem 7-bp repeats located upstream of
hmw1A and hmw2A, the structural genes that encode these
adhesive proteins. High numbers of repeats result in low levels
of protein expression, and low numbers of repeats result in
high levels of protein expression. To extend these observations,
we examined paired H. influenzae isolates from the nasophar-
ynx and middle ear regions of two children with acute middle
ear infections (7). In both patients, low numbers of hmw1A and
hmw2A repeats and high levels of HMW1 and HMW2 were
observed in the nasopharyngeal isolates, while high numbers of
hmw1A and hmw2A repeats and low levels of HMW1 and
HMW2 were observed in the middle ear isolates, demonstrat-
ing that phase variation of HMW1 and HMW2 occurs during
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H. influenzae disease. During in vitro cultivation, the rate of
variation in 7-bp repeats is approximately 103, with some
variation from strain to strain and locus to locus (D. M. Cholon
and J. W. St. Geme III, unpublished data).
In patients with chronic obstructive pulmonary disease
(COPD), H. influenzae is frequently present in the lower air-
ways, both at the time of acute clinical exacerbations and
during clinically stable periods (10, 12). In these patients, H.
influenzae infection of the lower respiratory tract often persists
for extended periods of time. Although patients with COPD
have abnormalities in mucociliary clearance, a full understand-
ing of the factors influencing H. influenzae persistence in the
lower respiratory tract is lacking.
In this study, we characterized the HMW1 and HMW2 pro-
tein levels and the corresponding hmw1A and hmw2A repeat
numbers in H. influenzae isolates collected serially from pa-
tients with COPD. In addition, we examined the titers of an-
tibodies against HMW1 and HMW2 in serum samples ob-
tained at the same time as the sputum isolates. We found that
expression of HMW1 and HMW1 decreased over time in most
patients, associated with high serum titers of HMW1/HMW2-
specific antibodies and reflecting progressive increases in the
numbers of 7-bp repeats.
MATERIALS AND METHODS
Bacterial strains and growth conditions. H. influenzae strains and serum sam-
ples were recovered from patients with COPD at serial visits to an outpatient
clinic in the Buffalo Veterans Affairs Medical Center, as described previously
(12). Clinical information regarding the status of the patients’ chronic respiratory
symptoms (shortness of breath, cough, and sputum production) was obtained
during each visit in order to assess whether the patients were experiencing stable
disease or an exacerbation. A patient was defined as having an exacerbation
when the symptoms of shortness of breath, cough, sputum volume, and sputum
purulence were increased compared to baseline symptoms. A patient was defined
as having stable COPD when the symptoms were no different from those at
baseline levels. This study protocol was approved by the Human Studies Sub-
committee of the Veterans Affairs Western New York Healthcare System.
To determine whether serial isolates from a given patient were the same strain,
outer membrane protein profiles were examined by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis and chromosomal digests were exam-
ined by agarose gel electrophoresis (9).
H. influenzae strain 12 is a prototype nontypeable strain that was originally
recovered from the middle ear fluid of a patient with acute otitis media and is the
strain from which the hmw1 and hmw2 loci were first cloned. As controls in
experiments assessing levels of HMW1 and HMW2, we used derivatives of H.
influenzae strain Rd/HMW1 that contain various numbers of 7-bp repeats up-
stream of the hmw1A gene (Rd/HMW1-17R, Rd/HMW1-20R, and Rd/HMW1-
27R). Strain Rd/HMW1 contains the intact hmw1 locus and has been described
previously (8).
Bacteria were grown on chocolate agar plates and were stored at 80°C in
brain heart infusion broth with 20% glycerol (13).
Western blotting. To determine the relative amounts of HMW1 and HMW2
produced by serial isolates of nontypeable H. influenzae, bacteria were grown on
chocolate agar plates and were then resuspended in 10 mM HEPES buffer, pH
7.4, and sonicated. Protein concentrations in whole-cell sonicates were quantified
using the Bio-Rad reagent and were normalized for equivalent loading on a 7.5%
SDS-polyacrylamide gel electrophoresis gel. Western immunoblotting was per-
formed using polyclonal antiserum GP75, which was raised against HMW1 from
strain 12 and is broadly reactive with the HMW1/HMW2 family of adhesins (11).
Given the high level of homology and the variability in size among members of
the HMW1/HMW2 family (3, 5, 18), Western analysis does not allow differen-
tiation of HMW1 from HMW2 in a given strain. Accordingly, band intensities for
immunoreactive proteins were considered in aggregate and were quantified using
AlphaImager spot density tools. With this information, relative intensities for
serial isolates of a given strain were assigned values of /, , , or .
For purposes of display, the level of protein in the isolate with the highest
expression level in a given series was arbitrarily defined as, and comparison
levels were designated  for 75 to 100% of the maximum,  for 50 to 75%
of the maximum,  for 25 to 50% of the maximum, and / for 25% of the
maximum.
Repeat number analysis. To determine the numbers of 7-bp repeats upstream
of the hmw1A and hmw2A genes, individual bacterial colonies were resuspended
in sterile water and used as DNA templates for PCRs that amplified fragments
specific for the hmw1A and hmw2A upstream regions. These reactions exploited
primers that anneal to the unique regions upstream of the hmw1 and hmw2 loci
(primer 1679 anneals to the ORF upstream of hmw1A in strain 12, and primer
1598 anneals to the ORF upstream of hmw2A in strain 12) and a common
downstream primer, H1A (H1A anneals to sequences in both hmw1A and
hmw2A) (5). The hmw1- and hmw2-specific products were used as templates for
reactions with internal primers called Repeat5 and Repeat 3, which anneal to
sequences that immediately flank the hmwA repeat region in both the hmw1 and
the hmw2 loci (7). The products of these secondary reactions were separated on
3% MetaPhor agarose (Cambrex) gels, allowing resolution of 7-bp changes (7).
Given that the location of the gene encoding HMW1 varies from strain to strain
as either adjacent to ORF HI1679 or adjacent to ORF HI1598, with the gene
encoding HMW2 adjacent to the other ORF, we refer to the repeats in a given
strain as the 1679 repeats and the 1598 repeats.
ELISA methodology. Titers of human serum antibody directed against the
HMW1 and HMW2 proteins were determined by an enzyme-linked immunosor-
bent assay (ELISA) according to the method of Barenkamp, with minor modi-
fications (1). In brief, 96-well flat-bottomed assay plates (Falcon; Becton Dick-
inson) were coated with 2.5 g/ml of purified HMW1 protein recovered from H.
influenzae strain 12 in 0.1 M carbonate buffer, pH 9.6, and were incubated for 2 h
at 37°C and then overnight at 4°C. The next day, wells were washed three times
with 150 l of phosphate-buffered saline (PBS)-0.05% Tween 20, and then
human serum was added. All serum samples were serially diluted in PBS-0.05%
Tween 20-1% bovine serum albumin (Calbiochem) with a starting dilution of
1:100 (with the exception of the patient 31 samples, which were serially diluted
with a starting dilution of 1:800) and were incubated for 2 h at 37°C and then
overnight at 4°C. After three washes with 150 l of PBS-0.05% Tween 20, the
wells were incubated with a 1:10,000 dilution of monoclonal anti-human immu-
noglobulin G conjugated to horseradish peroxidase (Biosource) for 2 h at 37°C.
Subsequently, the wells were washed three times with 150 l of PBS-0.05%
Tween 20 and were then incubated with 100 l of a 1:1 mixture of solutions A
and B from the ABTS peroxide substrate system (KPL) for 20 min at room
temperature. The reaction was stopped using 100 l of 1% SDS, and the absor-
bance was monitored at 405 nm with a Quant universal microplate spectro-
photometer (Bio-Tek).
Adherence to primary airway epithelial cells. Human airway epithelial cells
were obtained from human trachea and large bronchial airway samples from
multiple individuals without lung disease under a protocol approved by the
University of Iowa Institutional Review Board. Adherence of bacterial isolates to
primary airway epithelial cells was measured as described previously (6). To
ensure reproducible and generalizable results, paired bacterial isolates from the
same patient were tested in the same assay at least three times, using cells from
three different individuals. Results for a representative assay using paired isolates
from each COPD patient are reported.
Statistical analysis. Differences in adherence between paired isolates from a
given patient were analyzed for statistical significance using a one-way analysis of
variance (ANOVA) for a factorial experimental design. The multicomparison
significance level for the ANOVA was 0.05. When significance was achieved by
one-way analysis, post-ANOVA comparison of means was performed using Bon-
ferroni’s multiple-comparison test.
RESULTS
Levels of HMW1/HMW2 expression in H. influenzae strains
isolated from patients with COPD. In the present study, we
performed Western analysis on whole-cell sonicates of H. in-
fluenzae isolates recovered serially from 11 patients with
COPD to assess the levels of HMW1 and HMW2 adhesins
expressed by these strains. As controls for these blots, we used
variants of strain Rd/HMW1 with 17, 20, or 27 tandem repeats
upstream of hmw1A. In order to plot relative amounts of
HMW1 and HMW2 protein expression, the intensities of the
bands were quantified using AlphaImager spot density tools.
Because it is not possible to differentiate HMW1 from HMW2
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in a given strain by Western analysis, we considered the
HMW1/HMW2 immunoreactive bands together for the pur-
pose of quantification. The relative intensities of HMW1 plus
HMW2 for serial isolates of a given strain were assigned values
of /, , , or  (Table 1). The level of protein in the
isolate with the highest expression level in the series from a
particular patient was arbitrarily defined as  for the pur-
pose of comparison with other isolates in the series. As sum-
marized in Table 1, 9 of the 11 patients had isolates that
displayed decreases in the amounts of HMW1 and HMW2
proteins over time. Figure 1 shows a representative Western
blot on five separate sets of isolates, including two discrete sets
that represent different strains from patient 56. These Western
blot analyses indicate that strains of H. influenzae isolated from
patients with COPD can express variable amounts of HMW1
and HMW2 and that the levels of these adhesins tend to
gradually decrease over time.
Relationship between levels of HMW1/HMW2 expression
and numbers of hmw1A and hmw2A repeats in H. influenzae
strains isolated from patients with COPD. To determine the
relationship between levels of HMW1 and HMW2 and num-
bers of 7-bp repeats upstream of the hmw1A and hmw2A genes
TABLE 1. Summary of HMW1/HMW2-like adhesin levels, hmw1A and hmw2A 7-bp repeat numbers, and HMW1/HMW2 antibody levels
associated with serial isolates of Haemophilus influenzae from patients with COPD
Patient
no. Visit no.
a Clinical statusb HMW proteinlevelc
No. of 7-bp repeats Serum antibody
titer by ELISA1679 1598
13 24 Exacerbation  14 16 1,557
30 Stable  17 18 6,590
36 Stable  19 22 5,400
22 1 Exacerbation  18 18 13,170
3 Stable  19 18 8,482
5 Stable / 21 19 11,476
24 17 Exacerbation  19 16 21,024
19 Stable  20 17 23,512
29 Stable  20 19 14,970
31 7 Exacerbation  17 19 96,056
12 Stable  17 22 50,400
48 28 Exacerbation  17 15 2,156
33 Stable  16 19 22,137
45 Stable / 19 22 8,415
54 24 Exacerbation  12 NAe 2,610
33 Stable  12 22 8,530
56d 10 Stable  16 17 9,147
12 Exacerbation  20 19 NDf
16 Stable  20 21 8,971
56d 34 Exacerbation  15 12 4,594
40 Stable  17 19 13,094
41 Exacerbation / 20 21 12,052
57 13 Exacerbation  15 17 5,689
15 Stable  19 20 32,120
20 Stable  19 18 11,746
74 1 Stable  17 18 6,515
2 Exacerbation / 17 19 11,554
14 33 Exacerbation  17 12 8,189
34 Stable  9 16 10,504
45 9 Exacerbation  17 15 78,336
10 Stable  19 14 60,088
11 Stable  18 14 116,192
a Visit number corresponds to the number of months after the initial visit to the COPD Clinic.
b “Exacerbation” refers to clinical exacerbation, and “stable” refers to stable clinical status. The criteria for exacerbation included an increase in symptoms compared
to baseline levels, and clinical status was considered stable when the symptoms were no different from baseline symptoms.
c Protein levels were based on quantification of bands from Western blot analysis by densitometry and represent total HMW1/HMW2 protein. In clinical isolates,
HMW1 and HMW2 cannot be distinguished from each other by Western analysis.
d Isolates on visits 10, 12, and 16 were distinct from isolates on visits 34, 40, and 41.
e NA, not applicable.
f ND, not determined.
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in the serial isolates, we performed colony PCR using primers
that distinguished hmw1A repeats from hmw2A repeats (re-
ferred to as 1679 repeats and 1598 repeats, based on the 5
primer and the adjacent ORF). In all cases where the quanti-
ties of HMW1 and HMW2 decreased over time, the decreases
in levels of HMW1 and HMW2 correlated with increases in
numbers of 7-bp repeats (Table 1). These data indicate that H.
influenzae isolates recovered from the sputum samples of pa-
tients with COPD contain variable numbers of 7-bp repeats
found upstream of hmw1A and hmw2A and that these numbers
tend to increase over time as the levels of HMW1 and HMW2
proteins decrease.
Levels of HMW-specific antibodies present in the serum
samples of patients with COPD. The HMW1 and HMW2
adhesins are known to be the predominant target of the serum
antibody response in patients with acute H. influenzae infection
(2), suggesting the hypothesis that bacteria expressing low
levels of HMW1 and HMW2 in the presence of HMW1/HMW2-
specific antibodies have a survival advantage. To test this hy-
pothesis, we used ELISA to measure titers of HMW1/HMW2-
specific antibodies present in serial serum samples from
patients with COPD. For the purpose of these assays, we used
purified HMW1 from H. influenzae strain 12. In all patients, we
found that HMW1/HMW2-specific antibody titers were high,
with no particular relationship between antibody titers and
levels of HMW1/HMW2 expression in the corresponding iso-
late (Table 1). Antibody titers were high even in patients who
had isolates with relatively stable total levels of HMW1 and
HMW2 over time.
Relationship between levels of HMW1/HMW2 expression
and adherence to primary airway epithelial cells by H. influ-
enzae strains isolated from patients with COPD. To determine
the relationship between levels of HMW1 and HMW2 and
capacity to adhere to airway epithelium, we performed adher-
ence assays with primary airway epithelial cells and the first
and last isolates from 10 serial sets, including 9 sets with de-
creases in levels of HMW1 and HMW2 over time and 1 set
with no change in levels of HMW1 and HMW2. As shown in
Fig. 2, in general there was little change in adherence between
the first and last isolates, even when the levels of HMW1 and
HMW2 decreased markedly, as highlighted with the isolates
from patients 22, 31, and 57 and the first set of isolates from
patient 56. In contrast, adherence decreased significantly in
association with reduction in levels of HMW1 and HMW2 in
isolates from patients 13 and 48 and the second set of isolates
from patient 56, all examples of isolates where the levels of
FIG. 1. Relationship between quantities of HMW1 and HMW2 protein levels and numbers of hmw1A and hmw2A repeats in serial isolates of
H. influenzae from patients with COPD. Whole-cell sonicates of bacterial isolates were prepared and then examined by Western blot analysis using
polyclonal antiserum GP75, which recognizes both HMW1 and HMW2. The numbers of hmw1A and hmw2A repeats were determined by PCR
on individual colonies by using primers that correspond to the HI1679 and HI1598 ORFs and distinguish the two hmw regions.
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HMW1 and HMW2 decreased from  to either  or /.
Interestingly, there was considerable strain-to-strain variation
in levels of adherence, independent of levels of HMW1 and
HMW2.
DISCUSSION
In the present study, we examined serial isolates of H. influ-
enzae recovered from the sputum samples of patients with
COPD to assess changes in levels of the HMW1 and HMW2
adhesins over time. We found that levels of HMW1 and
HMW2 typically decreased from high to low in association with
persistence. In all cases, the decreases in protein levels were
associated with progressive increases in the numbers of 7-bp
repeats upstream of the HMW1 and HMW2 structural genes,
consistent with earlier work demonstrating an inverse correla-
tion between the levels of HMW1 and HMW2 expression and
the numbers of 7-bp repeats found upstream of the hmw1A
and hmw2A genes (7). All patients had appreciable titers of
antibodies against the HMW1 and HMW2 proteins, as as-
sessed by ELISA using purified HMW1 from prototype H.
influenzae strain 12 as the antigen.
The HMW1 and HMW2 adhesins play an important role in
mediating adherence to host epithelium (15, 16). At the same
time, these proteins are highly immunogenic and are major
targets of the antibody response to infection (2). In earlier
work, we examined paired nasopharyngeal and middle ear
isolates of H. influenzae from patients with acute otitis media
and observed high levels of HMW1 and HMW2 in the naso-
pharyngeal isolates and low levels of HMW1 and HMW2 in
the middle ear isolates (7), suggesting that phase variation of
the HMW1 and HMW2 adhesins allows the organism to sur-
vive in diverse environments in the human host, including the
nasopharynx, where HMW1 and HMW2 facilitate coloniza-
tion, and middle ear fluid, where HMW1 and HMW2 may
enhance antibody-mediated clearance. Our results in the cur-
rent study argue that phase variation of HMW1 and HMW2 is
also important in allowing H. influenzae to persist in the lower
respiratory tract in patients with COPD. The fact that adults
generally have high titers of antibodies against the HMW1/
HMW2 proteins (2) suggests that serum antibody represents a
selective pressure against organisms with high levels of HMW1
and HMW2. However, since high antibody titers are present
even at the time of initial infection of the lower respiratory
tract in patients with COPD, presumably other selective pres-
sures against HMW1 and HMW2 also exist and play an im-
portant role when infection persists. It is possible that antibody
titers in respiratory mucosal secretions increase over the
course of infection and are a more important selective pres-
sure.
In comparing levels of adherence to airway epithelial cells by
serial isolates expressing variable levels of HMW1 and HMW2,
in most cases we observed similar levels of adherence, inde-
pendent of levels of HMW1 and HMW2. At the same time, in
three cases we found that lower levels of HMW1 and HMW2
resulted in reduced levels of adherence. These results suggest
that there may be some strain-to-strain variation in the quan-
tities of HMW1 and HMW2 required for full-level adherence,
perhaps reflecting the presence of other adhesive proteins or
other factors that modulate the adhesive activity and affinity of
HMW1 and HMW2. At this point, it is difficult to know what
selective advantage high levels of HMW1 and HMW2 confer
at early stages of infection of the lower respiratory tract.
In considering our adherence results with primary airway
epithelial cells, it is important to recognize that the airway cells
were grown immersed in tissue culture medium rather than at
an air-liquid interface. As a consequence, the cells were rela-
tively less differentiated and may have provided an imperfect
representation of epithelial cell-bacterium interactions in the
airway. Similarly, the characteristics of the airway cells were
likely distinct from the characteristics of nasopharyngeal cells.
It is interesting to compare the numbers of 7-bp repeats that
are associated with high, medium, and low levels of HMW1
and HMW2 expression among different strains. As an example,
in the strain from patient 22, 18 1679 repeats and 18 1598
repeats were associated with high levels of HMW1/HMW2,
whereas in the strain from patient 57, 18 1679 repeats and 19
1598 repeats were associated with low levels of HMW1/
HMW2. It is also interesting that with some strains, minimal
changes in repeat number result in a dramatic change in pro-
tein level, as highlighted by the strain from patient 74. In this
strain, 17 1679 repeats and 18 1598 repeats were associated
with high levels of HMW1 and HMW2 (isolate at visit 1), while
17 1679 repeats and 19 1598 repeats were associated with
negligible levels of HMW1 and HMW2 (isolate at visit 2).
Thus, an increase of one repeat unit resulted in marked de-
creases in HMW1 and HMW2 expression. Together, these
observations suggest that other factors influence the impact of
the hmw1A and hmw2A repeats on hmw1A and hmw2A gene
expression. Alternatively, independent of the repeats and lev-
FIG. 2. Adherence to primary airway epithelial cells by the first and last isolates from serial sets of H. influenzae from patients with COPD.
Percent adherence was determined by calculating the number of adherent CFU divided by the number of inoculated CFU. Paired bacterial isolates
from the same patient were tested at least three times using epithelial cells from three different individuals, and results for a representative assay
are reported. Asterisks indicate that the difference in adherence between bacterial isolates from the same patient was statistically significant.
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els of gene expression, there may be factors that influence
HMW1 and HMW2 production and stability.
The human host possesses a sophisticated immune system
for combating microbial intruders and protecting against dis-
ease. At the same time, bacterial pathogens have evolved cre-
ative mechanisms for evading host immunity, with phase vari-
ation representing one important example. In this study, we
demonstrated that nontypeable H. influenzae undergoes phase-
variable expression of the HMW1 and HMW2 adhesins in the
lower respiratory tracts of patients with COPD, resulting in
frequent selection against organisms expressing high levels of
HMW1 and HMW2. We speculate that phase variation of
HMW1 and HMW2 allows H. influenzae to persist in the lower
respiratory tract in patients with COPD.
ACKNOWLEDGMENTS
This work was supported by NIH grant DC-02873 (J.W.S.), NIH
grant HL082505 (D.C.L.), NIH grant AI19641 (T.F.M.), and the De-
partment of Veterans Affairs.
We are grateful to C. Chin for technical assistance.
REFERENCES
1. Barenkamp, S. J. 1996. Immunization with high-molecular-weight adhesion
proteins of nontypeable Haemophilus influenzae modifies experimental otitis
media in chinchillas. Infect. Immun. 64:1246–1251.
2. Barenkamp, S. J., and F. F. Bodor. 1990. Development of serum bactericidal
activity following nontypable Haemophilus influenzae acute otitis media. Pe-
diatr. Infect. Dis. J. 9:333–339.
3. Barenkamp, S. J., and E. Leininger. 1992. Cloning, expression, and DNA
sequence analysis of genes encoding nontypeable Haemophilus influenzae
high-molecular-weight proteins related to filamentous hemagglutinin of Bor-
detella pertussis. Infect. Immun. 60:1302–1313.
4. Barenkamp, S. J., and J. W. St. Geme III. 1994. Genes encoding high
molecular weight adhesion proteins of nontypeable Haemophilus influenzae
are part of gene clusters. Infect. Immun. 62:3320–3328.
5. Buscher, A. Z., K. Burmeister, S. J. Barenkamp, and J. W. St. Geme III.
2004. Evolutionary and functional relationships among the nontypeable Hae-
mophilus influenzae HMW family of adhesins. J. Bacteriol. 186:4209–4217.
6. Chin, C. L., L. J. Manzel, E. E. Lehman, A. L. Humlicek, L. Shi, T. D.
Starner, G. M. Denning, T. F. Murphy, S. Sethi, and D. C. Look. 2005.
Haemophilus influenzae from COPD patients with exacerbations induce
more inflammation than colonizers. Am. J. Respir. Crit. Care Med. 172:
85–91.
7. Dawid, S., S. J. Barenkamp, and J. W. St. Geme III. 1999. Variation in
expression of the Haemophilus influenzae HMW adhesins: a prokaryotic
system reminiscent of eukaryotes. Proc. Natl. Acad. Sci. USA 96:1077–1082.
8. Grass, S., A. Z. Buscher, W. E. Swords, M. A. Apicella, S. J. Barenkamp, N.
Ozchlewski, and J. W. St. Geme III. 2003. The Haemophilus influenzae
HMW1 adhesin is glycosylated in a process that requires HMW1C and
phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthe-
sis. Mol. Microbiol. 48:737–751.
9. Krasan, G. P., D. Cutter, S. L. Block, and J. W. St. Geme III. 1999. Adhesin
expression in matched nasopharyngeal and middle ear isolates of nontype-
able Haemophilus influenzae from children with acute otitis media. Infect.
Immun. 67:449–454.
10. Murphy, T. F., A. L. Brauer, A. T. Schiffmacher, and S. Sethi. 2004. Persis-
tent colonization by Haemophilus influenzae in chronic obstructive pulmo-
nary disease. Am. J. Respir. Crit. Care Med. 170:266–272.
11. Rodriguez, C. A., A. Z. Buscher, A. L. Smith, J. W. St. Geme III, and E. E.
Adderson. 2003. Prevalence and distribution of adhesin genes in invasive
non-type b encapsulated Haemophilus influenzae. Infect. Immun. 71:1635–
1642.
12. Sethi, S., N. Evans, B. J. B. Grant, and T. F. Murphy. 2002. New strains of
bacteria and exacerbations of chronic obstructive pulmonary disease.
N. Engl. J. Med. 347:465–471.
13. St. Geme, J. W., III, and S. Falkow. 1990. Haemophilus influenzae adheres to
and enters cultured human epithelial cells. Infect. Immun. 58:4036–4044.
14. St. Geme, J. W., III. 1993. Nontypeable Haemophilus influenzae disease:
epidemiology, pathogenesis, and prospects for prevention. Infect. Agents
Dis. 2:1–16.
15. St. Geme, J. W., III. 2002. Molecular and cellular determinants of non-
typeable Haemophilus influenzae adherence and invasion. Cell. Microbiol.
4:191–200.
16. St. Geme, J. W., III, S. Falkow, and S. J. Barenkamp. 1993. High-molecular-
weight proteins of nontypable Haemophilus influenzae mediate attachment
to human epithelial cells. Proc. Natl. Acad. Sci. USA 90:2875–2879.
17. St. Geme, J. W., III, and S. Grass. 1998. Secretion of the Haemophilus
influenzae HMW1 and HMW2 adhesins involves a periplasmic intermediate
and requires the HMWB and HMWC proteins. Mol. Microbiol. 27:617–630.
18. St. Geme, J. W., III, V. V. Kumar, D. Cutter, and S. J. Barenkamp. 1998.
Prevalence and distribution of the hmw and hia genes and the HMW and Hia
proteins among genetically diverse strains of nontypeable Haemophilus in-
fluenzae. Infect. Immun. 66:364–368.
19. Surana, N. K., S. Grass, G. G. Hardy, H. Li, D. G. Thanassi, and J. W. St.
Geme III. 2004. Evidence for conserved architecture and physical properties
of Omp85-like proteins throughout evolution. Proc. Natl. Acad. Sci. USA
101:14497–14502.
20. Turk, D. C. 1984. The pathogenicity of Haemophilus influenzae. J. Med.
Microbiol. 18:1–16.
Editor: J. N. Weiser




arch 18, 2014 by W
ashington University in St. Louis
http://iai.asm
.org/
D
ow
nloaded from
 
